Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rand Arafeh

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Cancer Research|December 22, 2022
Systematic Interrogation of Tumor Cell Resistance to Chimeric Antigen Receptor T-cell Therapy in Pancreatic CancerKimberly R Hagel, Rand Arafeh, Sydney Gang, et al.
Nature|September 23, 2021
Biologically informed deep neural network for prostate cancer discoveryHaitham A Elmarakeby, Justin Hwang, Rand Arafeh, et al.
Nature Communications|July 1, 2018
Harnessing synthetic lethality to predict the response to cancer treatmentJoo Sang Lee, Avinash Das, Livnat Jerby-Arnon, et al.
Elife|May 13, 2022
CREB5 reprograms FOXA1 nuclear interactions to promote resistance to androgen receptor-targeting therapiesJustin H Hwang, Rand Arafeh, Ji-Heui Seo, et al.
Nature Genetics|October 27, 2015
Recurrent inactivating RASA2 mutations in melanomaRand Arafeh, Nouar Qutob, Rafi Emmanuel, et al.
Nature Communications|March 31, 2021
Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancerSylvan C Baca, David Y Takeda, Ji-Heui Seo, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Cancer Research|December 22, 2022
Systematic Interrogation of Tumor Cell Resistance to Chimeric Antigen Receptor T-cell Therapy in Pancreatic CancerKimberly R Hagel, Rand Arafeh, Sydney Gang, et al.
Nature|September 23, 2021
Biologically informed deep neural network for prostate cancer discoveryHaitham A Elmarakeby, Justin Hwang, Rand Arafeh, et al.
Nature Communications|July 1, 2018
Harnessing synthetic lethality to predict the response to cancer treatmentJoo Sang Lee, Avinash Das, Livnat Jerby-Arnon, et al.
Elife|May 13, 2022
CREB5 reprograms FOXA1 nuclear interactions to promote resistance to androgen receptor-targeting therapiesJustin H Hwang, Rand Arafeh, Ji-Heui Seo, et al.
Nature Genetics|October 27, 2015
Recurrent inactivating RASA2 mutations in melanomaRand Arafeh, Nouar Qutob, Rafi Emmanuel, et al.
Nature Communications|March 31, 2021
Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancerSylvan C Baca, David Y Takeda, Ji-Heui Seo, et al.
Pageof 2